<

 
Data updated 2025-07-22 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date19731334.9 (espacenet)  (Federated)  (European Patent Register), 20190503
Patent/reg. no. and dateDK/EP 3793609, 20231213
Publication date20210324
Priority no. and dateUS 201862671208 P, 20180514, US 201962835278 P, 20190417
EP pub. no. and date EP 3793609 20210324
Effective date
Applicant/ownerPfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US
Applicant ref. no.
InventorJAIN, Ashwinkumar, c/o Pfizer Inc. 445 Eastern Point Road, Building
98
Groton, Connecticut 06340, US,
YU, Weili, c/o Pfizer Inc. 445 Eastern Point Road, Building
98
Groton, Connecticut 06340, US
Representative
Opponent
IPC ClassA61K 31/519 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) 
TitleORAL SOLUTION FORMULATION
Int. application no.IB2019053650
Int. publication no.WO2019220253
Related patent (certificate)
StatusEnhedspatent registreret
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact